Jacobio Pharmaceuticals Co., Ltd. clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 0 with minor changes only.

1. Notable

   JAB-23E73 · Advanced Solid Tumors With KRAS Alteration

   Primary completion pushed from Nov 2027 to Nov 2028

   Also in this update: Primary endpoint(s) modified; Enrollment increased: 294 → 344 participants

   Jacobio Pharmaceuticals Co., Ltd.·Phase 1/2· NCT06973564· Registry history of NCT06973564 on ClinicalTrials.gov (opens the registry)

   Oct 16, 2026

2. Notable

   JAB-8263 · JAB-8263 · Active Rheumatoid Arthritis

   Recruitment opened

   Jacobio Pharmaceuticals Co., Ltd.·Phase 2· NCT07684157· Registry history of NCT07684157 on ClinicalTrials.gov (opens the registry)

   Sep 28, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.